Smilax Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Jaipur, Rajasthan, India, established in 1991.
1991 Jaipur, Rajasthan, India Active
Last Updated:
Access Report
About Smilax Pharmaceuticals Private Limited

Smilax Pharmaceuticals Private Limited, a active private limited company, was established on 08 July 1991 in Jaipur, Rajasthan, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232RJ1991PTC006078. Registered under ROC Roc Jaipur. it is unlisted. It has an authorized capital of ₹1.50 Cr and a paid-up capital of ₹1.40 Cr.

It upholds a compliant status. Its leadership includes Mukut Bihari Goyal (Director), Mukta Goyal (Director). It holds no open charges and ₹5.00 M settled loans. Its latest AGM occurred on 27 September 2025, with the balance sheet filed on 31 March 2025. It is based at 66, Mathur Vaishya Nagar, Tonk Road,, Jaipur, Rajasthan, 302015.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232RJ1991PTC006078

  • Registration Number

    006078

  • Incorporation Date

    08 July 1991

  • Authorized Capital

    ₹1.50 Cr

  • Paid-Up Capital

    ₹1.40 Cr

  • ROC Code

    Roc Jaipur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.50 Cr
  • Paid Up Capital ₹ 1.40 Cr
  • Company Age 34 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
  • Satisfied Charges ₹ 5.00 M
  • Revenue Growth **** %
  • Profit Growth **** 113.37%
  • Ebitda **** 14.06%
  • Net Worth 0.03%
  • Total Assets **** 0.03%
Company report

Smilax Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Smilax Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Smilax Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Mukut Bihari Goyal Director 08 Jul 1991 Current
Mukta Goyal Director 08 Jul 1991 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Smilax Pharmaceuticals.

Smilax Pharmaceuticals Private Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 113.37% increase in profit. The company's net worth moved up by a moderate rise of 0.03%.

Smilax Pharmaceuticals revenue growth over time
Smilax Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 0.03%
*******
*******
*******
*******
Profit or Loss
*******
 113.37%
*******
*******
*******
*******
Net Worth
*******
 0.03%
*******
*******
*******
*******
EBITDA
*******
 14.06%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Smilax Pharmaceuticals?

In 2024, Smilax Pharmaceuticals had a public holding of 35.71%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹5,000,000.00

Charges Breakdown by Lending Institutions
  • Union Bank Of India : 0.50 Cr
Latest Charge Details
Date Lender Amount Status
26 Mar 2009 Union Bank Of India ₹5.00 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Smilax Pharmaceuticals?

Unlock and access historical data on people associated with Smilax Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Smilax Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Smilax Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Smilax Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Smilax Pharmaceuticals Private Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Smilax Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jaipur. was recorded as a recent event.

  • Charges

    The activity A charge registered on 26 Mar 2009 via Charge ID 10158423 with Union Bank Of India was fully satisfied on 05 Feb 2019. was completed.

  • Charges

    The activity A charge with Union Bank Of India amounted to Rs. 0.50 Cr with Charge ID 10158423 was registered on 26 Mar 2009. was completed.

  • Director Appointment

    Progress on Mukut Bihari Goyal was appointed as a Director was appointed as a Director on 08 Jul 1991 & has been associated with this company since 34 years 8 months . was documented.

  • Director Appointment

    Mukta Goyal was appointed as a Director was appointed as a Director on 08 Jul 1991 & has been associated with this company since 34 years 8 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Smilax Pharmaceuticals Private Limited?

The CIN of Smilax Pharmaceuticals Private Limited is U24232RJ1991PTC006078.

Where is Smilax Pharmaceuticals Private Limited headquartered?

Smilax Pharmaceuticals Private Limited is headquartered at 66, Mathur Vaishya Nagar, Tonk Road,, Jaipur, Rajasthan, 302015.

When was Smilax Pharmaceuticals Private Limited incorporated?

Smilax Pharmaceuticals Private Limited was incorporated on 08 July 1991.

Who are the current directors of Smilax Pharmaceuticals Private Limited?

The current directors of Smilax Pharmaceuticals Private Limited are

What is the primary industry of Smilax Pharmaceuticals Private Limited?

The primary industry of Smilax Pharmaceuticals Private Limited is Manufacturing.

Is Smilax Pharmaceuticals Private Limited a listed company?

Smilax Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Smilax Pharmaceuticals Private Limited?

The authorized capital of Smilax Pharmaceuticals Private Limited is ₹1.50 Cr, and the paid-up capital is ₹1.40 Cr.

What is the compliance status of Smilax Pharmaceuticals Private Limited?

The compliance status of Smilax Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available